Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis brand, Aphria, has launched CBN Night Oil, the brand’s first CBN oil medical product formulated for patients’ nighttime use.

Blair MacNeil, President, Tilray Canada, said, “Tilray Medical is committed to providing patients in Canada and around the globe with safe, high-quality cannabinoid-based medicine. We are pleased to add a dedicated night oil to the Aphria medical portfolio and broaden our offering of effective medical cannabis products to patients with a wider range of needs.”

CBN, or cannabinol, is derived from THC and is known to help improve the duration and quality of sleep.1 Aphria’s CBN-dominant oil is carefully formulated with 30mg CBN per mL and 10mg THC per mL (in a 50mL bottle) and is composed of broad-spectrum cannabis distillate. Designed to be used in conjunction with a nighttime routine, Aphria’s CBN Night Oil is now available across Canada.